Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ketotifen fumarate
Cat. No.:
OB0225LY-0137
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Ketotifen fumarate is an antihistamine and acts as a mast cell stabilizer.
Synonym:
HC 20511 fumarate; 34580-14-8; Ketotifene; Ketotifeno; Ketotifenum; 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one; 2-(1-Methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one; 4-(1-Methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one; 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one
CAS No.:
34580-14-8
Compound CID:
3827
Formula:
C23H23NO5S
Formula Weight:
425.5
Specification
Relative Density:
1.236 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ketotifen fumarate is mainly used to control allergic diseases, including asthma and allergic rhinitis.
Library Information
Targets:
Histamine receptor; PDE
Receptors:
H1 receptor
Pathways:
Neuronal signaling; GPCR/G protein; Immunology/Inflammation; Metabolism
Plate Number:
AOCL-2
Plate Location:
f10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 129.26 mM
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
